InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-1.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Amman Bradford K., Chief Financial Officer. Director active across 1 company, notably Vivos Therapeutics, Inc.. In total, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €4k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Amman Bradford K.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
250,000 shares@ US$0.41Common StockSEC:0001493152-26-040238:0
1,000 shares@ US$5.29100.0% of flowCommon StockSEC:0001493152-21-012902:0
Canonical exit: 23 Aug 2021 (T+90)
2 of 2 declarations
About Amman Bradford K.
Bradford K. Amman is the Chief Financial Officer at Vivos Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health and sustainable growth of the organization.
